Adiuvo Investments's EBIT per Share for the
three
months ended in Mar. 2026 was zł-0.10.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was zł-0.04.
During the past 3 years, the average EBIT per Share Growth Rate was 38.60% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 32.00% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 24.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Adiuvo Investments's EBIT per Share or its related term are showing as below:
WAR:ADV'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -10.8 Med: 21.9 Max: 46.9
Current: 38.6
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Adiuvo Investments was 46.90% per year. The lowest was -10.80% per year. And the median was 21.90% per year.
WAR:ADV's 3-Year EBIT Growth Rate is ranked better than 83.26% of 687
companies
in the Medical Devices & Instruments industry
Industry Median: 9.4
vs WAR:ADV: 38.60
Adiuvo Investments (WAR:ADV) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Adiuvo Investments EBIT per Share Related Terms
Adiuvo Investments EBIT per Share Historical Data
* Premium members only.
The historical data trend for Adiuvo Investments's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-0.04
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Adiuvo Investments (WAR:ADV) has a EBIT per Share of zł-0.04 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Adiuvo Investments and its competitors. According to the industry distribution chart, Adiuvo Investments ranks #115 out of 687 companies in the Medical Devices & Instruments industry, placing it in the top 16.7%.
Is Adiuvo Investments' EBIT per Share too high?
Adiuvo Investments' current EBIT per Share is zł-0.04. Based on the distribution chart, Adiuvo Investments ranks #115 out of 687 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Adiuvo Investments has a GF Score™ of 30/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Adiuvo Investments' EBIT per Share compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Adiuvo Investments ranks #115 out of 687 companies for EBIT per Share. This places Adiuvo Investments in the top 17% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 9.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.40, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Adiuvo Investments and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adiuvo Investments's current EBIT per Share is zł-0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adiuvo Investments stock overvalued right now?
Based on GuruFocus' analysis, Adiuvo Investments (WAR:ADV) is currently considered Fairly Valued. The stock's GF Value™ is zł0.46, compared to a current price of zł0.43 — trading 7.6% below its estimated fair value. The current EBIT per Share is zł-0.04. Adiuvo Investments' overall GF Score™ is 30/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Adiuvo Investments (WAR:ADV), the current EBIT per Share is zł-0.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Adiuvo Investments (WAR:ADV) Overvalued in 2026?
Based on GuruFocus' analysis, Adiuvo Investments stock appears to be undervalued.
The current stock price of zł0.43 is trading 7.6% below its estimated GF Value™ of zł0.46.
GuruFocus considers Adiuvo Investments to be Fairly Valued.
Key valuation signals for WAR:ADV:
EBIT per Share: zł-0.04
GF Value™: zł0.46 vs. price of zł0.43 (7.6% below fair value)
No single metric tells the full story. See the WAR:ADV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Adiuvo Investments SA is engaged in the selection, development, financing and commercialization of projects in the international market. The new technologies developed by the company focus on disease management, monitoring healthy lifestyle and treatment with the help of mobile devices and supplementation and functional food, or food, which in addition to nutritional properties also has health properties.
30GF Score
Get the complete analysis for WAR:ADV
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:ADV has been successfully added to your 
